// App-Quantinova.ai

1257 : Recommendation on Colchicine Dosing and Definition of Colchicine Resistance/Intolerance in the Management of Familial Mediterranean Fever

Researchers

Presenter

  • Erdal Sag

Principal Investigators

  • Eldad Ben-Chetrit

  • Marco Gattorno

  • Ahmet Gul

  • Philip Hashkes

  • Isabelle Kone-Paut

  • Helen Lachmann

  • Elena Tsitsami

  • Marinka Twilt

  • Fabrizio De Benedetti

  • Jasmin B. Kuemmerle-Deschner

Medical Centers

  • Hacettepe University, Ankara, Turkey

  • Hacettepe University, Ankara, Turkey

  • Hebrew University of Jerusalem, Jerusalem, Israel

  • Istituto Giannina Gaslini, Genoa, Italy

  • Istanbul University, Istanbul, Turkey

  • Shaare Zedek Medical Center, Jerusalem, Israel

  • Rhumatologie pédiatrique et CEREMAIA,, Université Paris-Sud Saclay, Paris, France

  • The Royal Free Hospital & University College London, London, United Kingdom

  • National and Kapodistrian University of Athens, Athens, Greece

  • University of Calgary, Calgary, AB, Canada

  • Bambino Gesu Childrens Hospital, Rome, Italy

  • University of Tubingen, Tubingen, Germany

Locations

  • Turkey

  • Israel

  • Italy

  • France

  • United Kingdom

  • Greece

  • Canada

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Familial Mediterranean fever

Biomarkers

  • N/A

Drug/Treatment

  • Colchicine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved